Pages that link to "Q36375260"
Jump to navigation
Jump to search
The following pages link to An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc (Q36375260):
Displaying 50 items.
- Diversity and recognition efficiency of T cell responses to cancer (Q24796652) (← links)
- Type I interferon response and innate immune sensing of cancer (Q27023235) (← links)
- Ex vivo characterization of tumor-derived melanoma antigen encoding gene-specific CD8 cells in patients with hepatocellular carcinoma (Q28191190) (← links)
- mRNA expression of tumor-associated antigens in melanoma tissues and cell lines (Q28218733) (← links)
- Host type I IFN signals are required for antitumor CD8 T cell responses through CD8{alpha} dendritic cells (Q28248489) (← links)
- Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen (Q30767834) (← links)
- Flow cytometric enumeration of antigen-specific T lymphocytes. (Q33198743) (← links)
- Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines (Q33255244) (← links)
- Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma. (Q33284046) (← links)
- T-cell recognition of melanoma-associated antigens (Q33827458) (← links)
- CD40 stimulation accelerates deletion of tumor-specific CD8( ) T cells in the absence of tumor-antigen vaccination (Q33943864) (← links)
- Detection of antigen-specific cytotoxic T lymphocytes: significance for investigative dermatology (Q34022532) (← links)
- Design and evaluation of antigen-specific vaccination strategies against cancer. (Q34046858) (← links)
- A Screening Assay to Identify Agents That Enhance T-Cell Recognition of Human Melanomas (Q34074758) (← links)
- Immunity against cancer: lessons learned from melanoma. (Q34167925) (← links)
- Cell function-based flow cytometry (Q34223166) (← links)
- Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens (Q34265381) (← links)
- Ex vivo analysis of tumor antigen specific CD8 T cell responses using MHC/peptide tetramers in cancer patients (Q34311750) (← links)
- Development and use of multimeric major histocompatibility complex molecules (Q34550189) (← links)
- Tracking T cells with tetramers: new tales from new tools (Q34632077) (← links)
- A broad profile of co-dominant epitopes shapes the peripheral Mycobacterium tuberculosis specific CD8 T-cell immune response in South African patients with active tuberculosis (Q34650335) (← links)
- Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? (Q34669820) (← links)
- The T-cell response in patients with cancer (Q34956078) (← links)
- Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. (Q35005935) (← links)
- Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction (Q35008630) (← links)
- Melacine: an allogeneic melanoma tumor cell lysate vaccine (Q35194168) (← links)
- Derangement of immune responses by myeloid suppressor cells (Q35573513) (← links)
- Immunologic monitoring. (Q35583546) (← links)
- Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. (Q35595698) (← links)
- Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy (Q36371527) (← links)
- Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes (Q36835348) (← links)
- Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patients (Q37020244) (← links)
- Signaling defects in anti-tumor T cells (Q37063739) (← links)
- Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines (Q37137360) (← links)
- Impaired interferon signaling is a common immune defect in human cancer (Q37211332) (← links)
- Induction of tolerance to immunogenic tumor antigens associated with lymphomagenesis in HOX11 transgenic mice (Q37291942) (← links)
- Systematic evaluation of immune regulation and modulation (Q37713498) (← links)
- Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why? (Q37873379) (← links)
- Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine. (Q38291127) (← links)
- Targeting WNT1-inducible signaling pathway protein 2 alters human breast cancer cell susceptibility to specific lysis through regulation of KLF-4 and miR-7 expression. (Q38984559) (← links)
- Induction of cytotoxic T lymphocytes from peripheral blood of human histocompatibility antigen (HLA)-A31( ) gastric cancer patients by in vitro stimulation with antigenic peptide of signet ring cell carcinoma (Q39288664) (← links)
- Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond (Q39506976) (← links)
- Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy (Q39741122) (← links)
- Cytotoxic T lymphocytes directed to the preferentially expressed antigen of melanoma (PRAME) target chronic myeloid leukemia (Q39966752) (← links)
- Downregulation of IFN-gammaR in association with loss of Fas function is linked to tumor progression (Q40071671) (← links)
- Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity. (Q40236620) (← links)
- Qualitative difference between the cytotoxic T lymphocyte responses to melanocyte antigens in melanoma and vitiligo. (Q40362128) (← links)
- Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice (Q40579511) (← links)
- Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity (Q40605353) (← links)
- CD40 expressed on human melanoma cells mediates T cell co-stimulation and tumor cell growth (Q40876094) (← links)